Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial - Wikidata - awgldk - TriplyDB

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

http://www.wikidata.org/entity/Q33653406

about

Nonmyeloablative allogeneic hematopoietic cell transplantation Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia.Reduced-intensity conditioned allogeneic SCT in adults with AML.Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis.Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing camelia sinensis leaf extract.Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience.

P2860

Q26748780-7B1997ED-0496-452A-BADD-99DE71820139 Q35143457-FCE4D6B2-11D7-4208-92FB-3377D82E0F4C Q35223780-5E23630C-4943-428D-947D-221273FAED2D Q36055055-54952DB3-90F6-400F-842A-FEB15D7475B5 Q36212400-2882F102-3993-4170-ACDF-0E4E5E53E272 Q37419348-180290A5-8157-4DB9-8D5F-5EBABFA50270 Q38366632-DE25EFCE-A1CE-46B8-B21A-B8D0422C703F Q38755378-B5719CCF-FDAC-4DE9-9A88-371C4A531385 Q43080886-5BE0C700-C718-40A1-B43C-D4EC5BA18654 Q49283386-567EC314-8EC5-4588-B691-E0A571C1FD5F

P2860

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

http://www.wikidata.org/entity/Q33653406

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@ast

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@en

type

label

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@ast

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@en

prefLabel

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@ast

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@en

P1433

Q33653406-60EE0E1D-4CE0-405A-AC3F-CEF8024C9D63

P1476

Q33653406-F928EEAC-3856-47D6-9814-7C6DF6B5C0B5

P2093

Q33653406-07D7740D-DBD2-44EC-9CFD-60113A89C38C

Q33653406-20677391-1E49-4442-85EC-54BDAF62F0BC

Q33653406-2BA40C9D-BE84-4F62-A915-EE606A15C94E

Q33653406-34A34F37-9A19-4D30-9BF1-738E1271B3C3

Q33653406-55246FC1-622B-4689-9786-7CCDFEED35C3

Q33653406-64997AAA-456D-422B-899B-A3431AD28817

Q33653406-8C9BAE88-3755-4C51-95BC-88C8B9746AAF

Q33653406-B8671F24-8ED8-4BFC-876E-D91C31E38C73

Q33653406-C24396C7-CC66-4911-B7EB-632E618E24BC

Q33653406-C588F4F0-E5E3-447A-B5CE-2CE9023D11D4

P2860

Q33653406-0A531BBF-A3EC-4E1B-800B-4CEB8241B270

Q33653406-12A79133-6BCA-4E3C-B76D-856956F3D50F

Q33653406-18D433A8-3965-43A7-A1E0-9D9D9997B96E

Q33653406-1F0E3748-B87B-41B0-9801-6D5B3241B205

Q33653406-23646D8E-4945-442B-A4CF-D2120FCF10FD

Q33653406-23A7860A-600C-46AE-AC70-5C26C4C1C680

Q33653406-2F3BEAF8-E209-4228-9591-C3842BA4680B

Q33653406-3317CF25-A1A3-49DA-B4FB-9DC540E2F108

Q33653406-38C9D67B-545C-4DCC-8567-B95294C5D41B

Q33653406-3B02F55C-0AE5-4627-8B35-1D4855B24D27

P304

Q33653406-EEA2675E-E34A-48B7-BA29-0F3FBF7F44C4

P31

Q33653406-FAAFEF52-7D10-4441-A026-3D8A90818976

P356

Q33653406-17F21165-4978-45FA-837F-9852A176D83F

P433

Q33653406-3966C467-6BB6-473F-BCE3-FEE68D0DCB70

P478

Q33653406-160E74C8-6636-4D34-B98D-0B23132925CF

P50

Q33653406-06485B21-200F-4D8D-A8EA-E6677D593984

Q33653406-5024355B-E631-4EC3-AAA5-E90AC0E78EA7

Q33653406-7DDB715D-D65C-4CF6-857F-84A3F1058582

Q33653406-8A3F4459-3CC8-4B38-BC2C-B2567B745B62

Q33653406-9E7608A7-4A96-4102-ABBA-2AE977BD941B

P577

Q33653406-47CE4EE3-7CC8-4116-A77D-01A2191A2655

P5875

Q33653406-01234217-9130-4122-B8B8-791C13309913

P698

Q33653406-E8AF8959-434C-4ABA-9358-D6F0E3AC9D60

P921

Q33653406-4E639ADB-3BEA-472C-B490-865CE11BEBA5

P932

Q33653406-A3EA9210-3C1C-4086-926C-62CD19FF8121

P356

J.BBMT.2009.11.004

P1433

Biology of Blood and Marrow Transplantation

P1476

Low-dose total body irradiatio ...... ignancies: a multicenter trial

@en

P2093

Ann Woolfrey

http://www.w3.org/2001/XMLSchema#string

Benedetto Bruno

http://www.w3.org/2001/XMLSchema#string

Effie Petersdorf

http://www.w3.org/2001/XMLSchema#string

Finn B Petersen

http://www.w3.org/2001/XMLSchema#string

Hirohisa Nakamae

http://www.w3.org/2001/XMLSchema#string

James C Wade

http://www.w3.org/2001/XMLSchema#string

Jan Storek

http://www.w3.org/2001/XMLSchema#string

Jens Panse

http://www.w3.org/2001/XMLSchema#string

Michael A Pulsipher

http://www.w3.org/2001/XMLSchema#string

Michael B Maris

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.

Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).

Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantat

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

P304

384-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2009.11.004

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

David G. Maloney

Brenda M Sandmaier

Thomas R Chauncey

P577

2009-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38077434

http://www.w3.org/2001/XMLSchema#string

P698

19900571

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2822012

http://www.w3.org/2001/XMLSchema#string